Dr. B. Gnanaprakasam, Ph.D

Dr. B. Gnanaprakasam, , is a Associate Professor in the Departments of Chemistry, (IISER) at the Pune, INDIA, He earned his Bachelor's and Master's degree in Chemistry from University of Madras. He then pursued as a Senior Chemist at Dr. Reddy’s Laboratory, INDIA, Earned his Ph.D degree in (2008) in Chemistry from (CSMCRI) Bhavnagar University, Gujarat, INDIA. Further pursued his Postdoctoral research at Weizmann Institute of Science, Israel under the top Advisor, Prof. David Milstein, (2008-2011) and further worked as a Scientist I, at the Department of Organic Chemistry, Institute of Chemical and Engineering Sciences A*STAR Institute Singapore. (2011-2012).

To add to his feathers he received Alexander Von Humboldt Fellow at the Institute of Organic and Biomolecular Chemistry, University of Gottingen, Germany, under the top scientific chemist teams under the Advisor Prof. L. F Tietze. To his credit he published many top research papers in the reputed international journals. Attended many international seminars and symposium to present his esteem quality research work in the form of poster and prestigious invited talks. Dr. Gnanaprakasam, specializes and main research interest focuses on the Natural products synthesis, Asymmetric synthesis, Homogeneous catalysis, Flow chemistry, Fluorination methods. to understanding the complexity of chemical processes and to identify the suitable Natural products into effective therapeutic options.

Dr. Kamesh Ravichandran, Ph.D

Dr. Kamesh Ravichandran got his Ph.D. in Biochemistry in 2011 in the Department of Zoology, University of Madras. He is currently a Research Instructor in the Department of Biochemistry and Molecular Genetics, University of Colorado Denver. Dr. Ravichandran’s expertise is in small molecule drug discovery in cancer, autosomal dominant polycystic kidney disease (ADPKD) Onconephrology, and in acute kidney injury (AKI). Dr. Ravichandran has 10+ years of experience working with mice and rats, expertise in various modes of drug delivery, cell line, patient-derived tumor implantation, microsurgery, and ethical animal care. He is proficient in cell culture techniques of mammalian cells, primary cells, and murine embryonic stem cells, including differentiation assays and cell-based assays.

Dr. Ravichandran is skilled in molecular techniques, including tissue histology, PCR, chromatin biology, gene editing, and protein expression analysis. He has served as a Co-Principal Investigator in Ionis Pharma sponsored grant to study Antisense Oligonucleotide (ASO) in various preclinical genetic models of autosomal dominant polycystic kidney disease (ADPKD) and served as key personnel in various NIH and Veteran Affairs (VA) grants. He was awarded an outstanding research scholar by the American Federation of Medical Research in 2014. Overall, he has twenty-four publications, and two invited reviews in leading international journals and out of which he has 15 first and co-first author publications. His publications were selected for the cover page in the high impact AACR journals Clinical Cancer Research and Cancer Prevention Research. Research Contributions: Autosomal Dominant Polycystic Kidney Disease (ADPKD): He initiated preclinical trials using second-generation mTOR inhibitors like PP242, mTOR Antisense Oligonucleotide (ASO) in various genetic models of ADPKD has resulted in NIH initiated clinical trials and out of which PP242 is in phase 1 clinical trial for solid tumors and lymphomas. Onconephrology: This invivo model is the most appreciated and widely used preclinical model in onconephrology to date. The project's outcome resulted in the characterization of the IL-33/CD4 T cell/CXCL-8 axis in AKI with and without cancer.

Dr. Bharanidharan Devarajan, Ph.D

Dr. Bharanidharan Devarajan, is a scientist in the Departments of Bioinformatics and Microbiology, at the Aravind Medical Research Foundation, Madurai, India. He earned his Bachelor's and Master's degree in Biochemistry from University of Madras. He received his Ph. D (2007) in Computational Biology and X-ray crystallography from the Centre for Crystallography and Biophysics at University of Madras. He then pursued his Postdoctoral research at University of Alabama, Birmingham, USA (2008-2010) and Georgia Institute of Technology, Atlanta, USA (2010-2012).

Dr. Bharani, specializes in ocular cancer bioinformatics and systems biology, analysis of genome-wide expression profiles of mRNA and non-coding RNAs, biological pathway analysis, and computational analysis of alternate transcripts. His main research interest is in translational genomics of various eye disease and ocular cancer, to understanding the complexity of biological processes and to identify diagnostic molecular markers for more effective and personalized therapies.

Dr. Venkata Ramanarao Parasa, MBA, Ph.D

Venkata Ramanarao Parasa PhD is an accomplished Scientist and Skilled R&D Project Manager with 9 years of experience in both academia and industry across the field of infectious diseases, diabetes, cancer and auto-immune diseases. Parasa holds a Ph.D. in interdisciplinary biochemistry and immunology from University of Madras and a MBA in operations research. In his doctoral research, he developed rapid diagnostic assays and studied cellular responses in HIV-TB coinfection, which provided a solid cross-functional background across biochemistry, microbiology, cell biology, immunology and clinical research. Parasa then moved to Sweden and had worked as Postdoctoral Research Scientist in the prestigious Karolinska Institute and as Principal Research Scientist in Linköping University where his research was focused on development of alternative disease models to animal research, assay development and host-directed therapy. During his research career, Parasa had developed various invitro cell and immunological assays including the development of complex physiological invitro 3D human tissue disease models).

Since 2019, he has been working as Scientific Project Manager at EMPE Diagnostics AB, Sweden and is responsible for project management grant writing and scientific tasks. At EMPE, Parasa had delivered quantitative probes – for establishment of stringent QC methods, project management – clinical and product development of IVD, grant proposals – resulting in a total of €50000 over a period of one year, and SOPs – for commercial production of diagnostic tests. At VENBIOTECH Parasa is a member of Scientific Advisory team and will contribute with his expertise in 3D human tissue models, assay development and clinical research.